Health Condition 1: N979- Female infertility, unspecified Health Condition 2: null- Patients undergoing Invitro fertilisation
Conditions
Interventions
Intervention1: Transdermal Testosterone gel (Androgel from Besins Health care India Pvt Ltd.): Transdermal Testosterone gel (Androgel from Besins Health care India Pvt Ltd.) 12.5 mg
Sponsors
Besins Healthcare India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: Patients from whom 1.FSH 2.Normal TSH, Prolactin, hepatic and renal function 3.Normal uterine cavity as assessed by Hysteroscopy and 3D USG 4.None having taken any fertility medication like gonadotropins or clomiphene in the past 3 months. 5.Patients willing to participate in the trial
Exclusion criteria
Exclusion criteria: 1.Women with known causes of decreased ovarian reserve like endometriosis grade 3 or higher 2.Women with pre-existing comorbidities like uncontrolled Diabetes, Hypertension and other chronic diseases like Chronic liver or kidney disease 3.Women with known autoimmune disorders like SLE, Autoimmune hemolytic anemia 4.Abnormal parental karyotype Abnormal Uterine cavity such as thin endometrium, severe Adenomyosis 5.Women not willing to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of oocytes retrieved per cycleTimepoint: Number of oocytes retrieved per cycle | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare between 2 groups 1.Total dose and number of days of administration of Gonadotrophins ï?· Cycle cancellation rate 2.Fertilization rate 3.Cleavage rate 4.Number of good quality embryos 5.Biochemical pregnancy 6.Implantation rate 7.Clinical pregnancy rate 8.Ongoing pregnancy Rate 9.Pregnancy wastage or nonviable pregnancyTimepoint: To compare between 2 groups 1.Total dose and number of days of administration of Gonadotrophins ï?· Cycle cancellation rate 2.Fertilization rate 3.Cleavage rate 4.Number of good quality embryos 5.Biochemical pregnancy 6.Implantation rate 7.Clinical pregnancy rate 8.Ongoing pregnancy Rate 9.Pregnancy wastage or nonviable pregnancy | — |
Countries
India
Contacts
Public ContactDr Neeta Singh
All India Institute of Medical Sciences, New Delhi
Outcome results
None listed